Adenosine-to-inosine editing is an important mechanism for posttranscriptional gene regulation. The biochemical and structural features of inosine-edited RNAs are poorly characterized. Solution NMR studies of such RNAs requires the use of 13 C and 15 N isotope-labelling. However, the commonly used isotope-labelling approach based on in vitro transcription of the RNA from a DNA template is not applicable for studies of non-native RNA modifications due to the lack of specific coding for the modified nucleotide.
INTRODUCTION
The conversion of adenosine to inosine (A-to-I editing) in RNA involves deamination of the exocylic N6 amino group in adenine to the non-canonical residue inosine (Supplementary Fig. S1 ).
This reaction is catalyzed by a specific class of proteins (1) called Adenosine Deaminases Acting on RNA (ADARs). Since inosine is recognized as guanine by the translational machinery (2) , A-to-I editing provides a level of post-transcriptional regulation during gene expression, increases transcript diversity and as a consequence, protein structural and functional diversity. A-to-I editing is involved in various cellular events. Inosine is found in various ion channel-encoding mRNAs as well as viral . A-to-I editing was also shown to regulate alternative splicing (7) and antagonize another important RNA-based cellular process, RNA interference (8-10).
In one such example, a sequence found in exons 2 and 3 of the rat α-tropomyosin gene has been subjected to editing (11, 12) . As a result, a hyper-edited motif with four potential IU base pairs is formed with the sequences IIUI and UUIU (Fig. 1A) in the sense and anti-sense strands, respectively (11, 12) . A 20-nucleotide dimer fragment (Fig. 1A) comprising this motif has later been shown to be a binding target, as well as the potential cleavage substrate of the RNA induced silencing complex (RISC) component Tudor-SN (TSN), also known as SND1 or p100 (13, 14) . TSN is a multifunctional protein implicated in splicing (15), regulation of transcription (16) (17) (18) and apoptosis (19) as well as miRNA processing (20) . TSN was shown to specifically bind and cleave this inosine-edited RNA duplex (I-RNA, Fig. 1A ), while showing no binding or cleavage activity towards an RNA duplex where the inosine residues have been replaced with guanine (G-RNA) (13) . By binding and cleaving the I-RNA duplex, TSN is thought to exclude the RNA from further downstream events in the RNAi pathway (13).
In order to investigate the molecular basis for the TSN discrimination towards I-RNA, structural analysis of the latter is of great importance. So far, one duplex structure containing tandem I:U basepairs was characterized by X-Ray crystallography (21) . The authors propose that I:U base-pairs possess properties similar to their G:U counterparts and their presence does not strongly destabilize A-form RNA helices (21). In contrast, other biophysical studies using solution methods show that I:U base pairs have a more severe effect on the thermodynamic stability of A-form RNA than G:U base pairs (22) . NMR analysis of I-RNA can thus provide useful information to characterize the structure and conformational dynamics of this RNA in solution and help to address these ambiguities.
RNA structure determination by NMR is complicated by the high degree of signal overlap, especially for the sugar protons (23). This signal overlap can be greatly reduced by preparation of 13 as the substrate for RNA synthesis (24, 25) by in vitro transcription (26, 27) . For larger RNA (>30 nt), various selective as well as segmental labelling approaches have been used to further simplify NMR spectra. These approaches involve specific labelling of individual NTPs by chemical (28, 29) or enzymatic (30-33) synthesis, metabolic pathways (34-36), cleavage, and re-ligation of an unlabelled 5' or 3' RNA fragment to its 3' or 5' labelled counterpart respectively (37-39) and in vitro splicing of a labelled nucleotide into an otherwise unlabelled RNA chain or vice versa (40).
Inosine-specific isotope labelling presents itself with a number of unique challenges. In vitro transcription with inosine triphosphate in the place of its guanosine triphosphate counterpart has been performed before (11, 12) . However, due to the presence of both guanine and inosine residues in edited RNAs including the one studied here, site-specific incorporation of inosine residues by in vitro transcription is impossible. Post-transcriptional RNA deamination in vitro, is extremely challenging as high levels of editing by ADARs to generate the IIUI motif can only be achieved with longer RNA substrates (11, 12) . In addition to increasing the size of the RNA and further complicating spectral interpretation, such editing is usually not very specific and may result in the modification of other adenine residues in the edited construct (11, 41) .
Chemical synthesis of the corresponding phosphoramidites and their subsequent incorporation into RNA, offers an attractive alternative for inosine labelling. Moreover, chemical synthesis allows
site-specific isotope labelling of specific atoms within the residues of interest (28, 42, 43) . Here we report the synthesis and incorporation of a selectively labelled inosine into a 20-mer RNA duplex that is implicated in posttranscriptional regulation of gene expression and is recognized by the TSN protein (13, 14) . We demonstrate that this labelling greatly reduces spectral overlap and provides unambiguous structural information for the central IIUI motif in the I-RNA, showing that the four I:U base-pairs adopt a non-standard conformation.
MATERIAL AND METHODS

Chemical synthesis
Chemicals were purchased from Sigma-Aldrich, Fluka, ABCR or Acros organics and used without further purification. Solutions were concentrated in vacuo on a Heidolph rotary evaporator.
The solvents for organic syntheses were of reagent grade and purified by distillation.
Chromatographic purification of products was accomplished using flash column chromatography on Elmer Spectrum BX FT-IR spectrometer with a diamond-ATR (Attenuated Total Reflection) setup. The intensities are described as being weak (w), medium (m) or strong (s).
Synthesis of phosphoramidite
The phosphoramidite building block 1 (Fig. 2) was synthesized starting from commercially available 13 C 6 -glucose 2, which was converted into the glycosylation precursor 3 in five steps following literature procedure (44). The limited commercial availability of 13 C-containing starting material 3 necessitated these elaborate synthetic steps. The Glycosylation using Silyl-Hilbert-Johnson conditions furnished the ester protected nucleoside 6.
Cleavage of the ester groups yielded the free nucleoside 7 with a yield of 92%. In order to selectively protect the 2'-hydroxy group in satisfactory yields, a two-step procedure was necessary. First the 3'-and 5'-hydroxy groups were silyl protected to compound 8. Then the 2'-hydroxy functionality was TBSprotected with subsequent deprotection of the 3'-and 5'-hydroxy groups to obtain compound 9. DMTrprotection of the 5'-hydroxy group to compound 10 and introduction of the phosphoramidite functionality lead to building block 1, which was incorporated into RNA strands using solid phase synthesis.
RNA Solid Phase Synthesis
The syntheses of the oligonucleotides were performed on an ABI 394 DNA/RNA Synthesizer 15 N]-inosine phosphoramidite was incorporated into RNA using a standard protocol. The coupling times for the modified bases were increased to 20 min to ensure maximum coupling efficiency. The strands were treated with 1 mL ammonium hydroxide (28%)/methyl amine (40%) (1/1 v/v) for 10 minutes at 60 °C to cleave off the solid support and remove the permanent protecting groups. The sample was centrifuged and the supernatant was collected. The pellet was rinsed with 0.25 mL ddH 2 O and the combined solvents were evaporated to dryness using a SpeedVac plus CS110A or SPD 111V from Savant. The residue was taken up in 115 µL DMSO, 60 µL triethylamine and 75 µL HF·triethylamine. After incubation for 1.5 h at 65 °C 25 µL NaOAc (3 M) and 1 mL n-butanol were added and the tube was cooled to −80 °C for 1 h. The sample was centrifuged again, the supernatant was discarded, and the pellet was rinsed twice with 0.25 mL cold ethanol. Analysis and purification of the oligonucleotides were performed on a Waters HPLC system (Waters Alliance 2695 with PDA 2996, preparative HPLC: 1525EF with 2482 UV detector) with VP 250/10 Nucleosil 100-7 C 18 columns from Macherey Nagel using a gradient of 0.1 M triethylamine/acetic acid in water (buffer A) and in 80% acetonitrile (buffer B). The identity of the strands was determined by MALDI-MS. Spectra were processed with Topspin and NMRPipe (47) and analyzed using NMRVIEW (48).
MALDI-MS
Acquisition parameters described in Table 2 were used. For the NOESY spectra a mixing time of 100 ms was used. The data were zero filled to 2048×512 complex data points, followed by apodization using Lorentz-to-Gauss transformation and cosine functions in t 2 and t 1 , respectively, before Fourier transformation.
RESULTS
NMR analysis of the unlabelled inosine-edited RNA duplex
To characterize the structure of the inosine-edited RNA duplex and potential structural differences induced by A-to-I editing we used standard NMR experiments. A two-dimensional Figure S2 respectively), taking advantage of the pronounced spin diffusion. Some assignments could be obtained for the inosine containing tetranucleotide motif. The aromatic-anomeric walk was used to unambiguously determine H8 (or H6)/H1' intra-as well as inter-residue correlations for I9, I12, on the sense strand, and U29, I30 on the anti-sense strand (Fig. 1A) indicating that at least this part of the inosine-containing motif possesses a geometry resembling A-form RNA.
However, further resonance assignment of the inosine-containing motif, even in the aromaticanomeric region, proved ambiguous. Since the A-form geometry may be distorted in this part of the RNA, standard cross-peaks expected for this conformation (such as inter-residue H8 (or H6)/H1') may not be present. Due to the large extent of spectral crowding, the presence or the absence of such signals is impossible to ascertain. This is the case with potential I10H8/I9H1', U11H6/I10H1' signals.
Also the assignment of some inosine H2 resonances, in particular for I9 and I10, is complicated by signal overlap, which makes it difficult to determine whether these protons give rise to an NOE pattern similar to that of adenine H2 (23) or whether additional signals are also observed.
While partial assignment of the aromatic-anomeric region was achieved, assignment of ribose regions of the NOESY spectrum of the I-RNA is impossible due to severe signal overlap (Fig. 3A) . Of particular importance is the assignment of the ribose resonances of the residues of the inosinecontaining motif, as this region of the I-RNA may not adopt a standard A-form helix. To address this issue, we developed a site-specific isotope-labeling scheme for the inosine residues for NMR analysis of the I-RNA.
Choice of isotope-labelling scheme and
The I-RNA labelling scheme was designed with the purpose to provide as much information as possible on the conformation of the inosine residues and their NOE contacts with neighbouring residues and base pairs. While the ribose signals tend to overlap, base signals are better dispersed and provide the most useful information about the duplex conformation. Missing assignments for both Hence, we decided to specifically label the C8 and not the C2 position in order to be able to distinguish between the two. In addition to C8, N7 of the inosine base and all ribose carbons were 13 C and 15 N labelled (Fig. 1B) . While C8 labelling is useful to resolve NOEs to report on anti or syn conformation of the base, N7 labelling can be used to check for potential non-Watson-Crick hydrogen bonding interactions such as Hoogsteen base-pairing (52,53). The inosine phosphoramidite was synthesized using the scheme described in Materials and Methods with a yield of 92%.
Inosine-labelling simplifies assignments of the I-RNA duplex
The availability of The chemical shift of the H8 proton of I10, which is obscured due to signal overlap in the unlabelled I-RNA NOESY spectrum ( Fig. 3A) could be unambiguously determined using the NOESY-HSQC experiment (Fig. 3B) . Moreover, the lack of an inter-residue I10H8/I9H1' cross-peak conclusively demonstrates a clear deviation from A-form geometry in this region of the I-RNA duplex.
From the homonuclear NOESY spectrum, this conclusion could not be drawn due to severe spectral resonances display an NOE pattern similar to that of the adenine H2 counterparts: One cross-peak to the H1' of the residue located 3' of the inosine in question, and another to the H1' of the residue located 3' of the inosine's counter-base (Fig. 3B ). In addition, I30 H2 also displays a signal to the H1' of I10. This NOE would correspond to an inter-atom distance which is not in line with A-form helix geometry, further confirming that I10 adopts a non-standard conformation. For example, the ω 1 -edited, ω 2 -filtered NOESY shows cross-peaks only between a proton bound to 13 C in ω 1 and another proton bound to a 12 C in ω 2 . This allows the detection of an NOE cross-peak between inosine ribose or H8 protons and inosine H2 or any non-inosine protons close in 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 space ( Fig. 3D and Fig. 4A, center strip) . These signals are mostly inter-residue cross-peaks between inosine ribose protons and various aromatic protons of uracil residues located next to the inosine in question, or protons of residues flanking the motif, which also located next to the labelled inosine moieties. Thus, the edited-filtered NOESY experiment provides unambiguous assignments of the C13H6/I12H2', U31H6/I30H1', A8H2 I9H2' cross-peaks.
Isotope edited and filtered NOESY experiments resolve signal overlap
The ω 1 -edited, ω 2 -edited NOESY ( Fig. 3C and Fig. 4A, right strip) , on the other hand gives rise to an NOE between two protons only if both of them are 13 C bound. This experiment facilitated the assignment of inosine intra-residue as well as I9 and I10 inter-residue cross-peaks, as these two inosine moieties are located next to each other in the RNA. Using this experiment, cross-peaks such as I10H8/I10H2', I10H8/I9H3', I30H8/I30H3' and I12H8/I12H2' were successfully assigned.
These experiments have also allowed assignment of NMR signals with completely degenerate chemical shifts. For example, I10H8/I10H1' and I10H2/I10H1' cross peaks could be resolved as the I10 H8 proton is 13 C-bound, while the I10 H2 proton is not. As a result the first cross-peak appears in the edited-edited NOESY spectrum (Fig. 4A, right strip) , while the other was observed in its editedfiltered NOESY counterpart (Fig. 4A, center strip) . Similarly, the completely overlapping, I10H8/I10H2', I10H2/I10H2' and I10H8/I9H2' I10H2/I9H2' correlations can be assigned (Fig. 4B) . This demonstrates the great utility of the site-specific inosine isotope-labelling combined with isotopeedited and -filtered NMR experiments. Using a combination of these experiments almost all crosspeaks in the aromatic ribose (Fig. 3A) and the anomeric/ribose regions (data not shown) could be assigned.
Analysis of inosine base chemical shifts
The specific 15 N-labelling of the N7 in inosine residues can be exploited to probe for possible Hoogsteen base pairing of the inosine in the I-RNA duplex (Fig. 5A) . A distinctive upfield 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 RNA duplex, solution state methods such as NMR spectroscopy are preferable to study not only the structure but also characterize the dynamical features of the I-RNA. Due to the molecular weight of the I-RNA duplex isotopic labelling is required for high resolution structure determination. Enzymatic synthesis of either uniform or selectively labelled 13 C/ 15 N inosine monophosphate which is a precursor for the generation of guanine and adenine monophosphates has been described by Schultheisz et al (32) . However, enzymatic, residue-specific synthesis of 13 C/ 15 N labelled I-RNA RNA strands is impossible as both inosine and guanosine form base pairs with cytosines in the template strand.
Therefore chemical synthesis is the only viable alternative to produce isotopically labelled I-RNA.
Chemical synthesis of isotopically labelled ribophosphoramidites has been described previously.
In one such case,
13
C labelled ribose moieties were produced using 13 C labelled glucose as starting material (28). The appropriate unlabelled base was then attached to this sugar, and the resultant ribophosphoramidite was incorporated into the RNA at various specific positions (28). This kind of ribose labelling technique was shown to simplify NMR spectral assignments of poly CU and S6/S7
RNA constructs both in their free form, as well as when bound to their protein binding partnerspolypyrimidine tract binding protein and feminizing locus on X, respectively (28). In other work, synthetic incorporation of a single 13 C label at the C6 position of uridine and cytidine has also been outlined (42). A 13 C labelled methyl group was also successfully added to the 2'OH of a uridine residue to study the conformational dynamics of various RNA sequences (43). However in neither of these studies, inosine labelling was performed.
The presence of It has been postulated before that TSN recognition of the I-RNA occurs due to its distorted helical structure (14). Our data here provide support for this hypothesis as NMR chemical shift assignments of the inosine containing motif of the I-RNA indicate that this region indeed adopts a non-canonical helical conformation.
In conclusion, an isotopically labelled, inosine containing RNA duplex with selective isotopic labels was successfully synthesized and analysed by NMR spectroscopy. This analysis has revealed a clear deviation from A-form geometry for the inosine containing portion of this RNA. Further structural and functional studies need to be conducted to gain additional insight into the exact nature of this deviation, as well its role in TSN recognition.
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HRMS (ESI−
)
2'-(O′-
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